Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Texas | 42,045 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 42,045 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4501-4520 of 42,045 trials

UnknownComparison of Two Techniques for Epiretinal or Internal Limiting Membrane PeelEpiretinal membranes (ERM) are cellular membranes on the surface of the retina that result in distortion of the vision (metamorphopsia), and decreased best-corrected visual acuity.NCT00892619·Houston, Texas and 1 other

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

CompletedBioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed ConditionsThe objective of this study was to prove the bioequivalence of losartan potassium/hydrochlorothiazide 100/25 mg tablet under fed conditions.NCT01102465·Austin, Texas

TerminatedSafety of 1 g and 2 g of Cefazolin in Pediatric SubjectsThis is a Phase 4, open-label, single-dose, parallel-group, multicenter, safety study of cefazolin (1 g or 2 g) in pediatric subjects between 10 and 17 years of age (inclusive)…NCT03231228·Little Rock, Arkansas and 4 others

Active not recruitingA Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)The main objective of the study is to characterize safety and efficacy of 2 dose levels of anvumetostat by investigator, and to evaluate anvumetostat monotherapy efficacy by…NCT06593522·Duarte, California and 90 others

CompletedEvaluation of a Johnson & Johnson Vision Care Investigational Contact Lens Compared to a Marketed Monthly Replacement Contact LensRandomized, double-masked, controlled, 2-arm parallel group, multi-site, 3-month dispensing study of Johnson \& Johnson Vision Care, Inc. (JJVCI) Investigational contact lens…NCT02515994·Jacksonville, Florida and 9 others

RecruitingMetabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 PatientsObjectives: The aim of the present study is to assess the significance of metabolomics and genetics in diagnosing and survival evaluation for pNET in the periodic follow-up of…NCT03048266·Houston, Texas

TerminatedBardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYSTThis study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with connective tissue disease-associated pulmonary arterial hypertension to…NCT02657356·Phoenix, Arizona and 105 others

RecruitingStudy to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial CancerThe purpose of this study is to compare how well Rina-S (GEN1184) works compared to treatment of physician's choice (paclitaxel or doxorubicin) that are considered standard…NCT07166094·Mobile, Alabama and 170 others

Active not recruitingA Phase 2 Study of ONO-2808 in Patients With Multiple System AtrophyThis is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of multiple doses of…NCT05923866·Fountain Valley, California and 34 others

CompletedCabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency VirusThis phase I trial studies the side effects and best dose of cabozantinib s-malate in treating patients with solid tumors that have spread to other places in the body and usually…NCT01822522·La Jolla, California and 19 others

CompletedNeuroprotection in Patients Undergoing Aortic Valve ReplacementTo evaluate the efficacy and safety of embolic protection devices to reduce ischemic brain injury in patients undergoing surgical aortic valve replacement (AVR).NCT02389894·Los Angeles, California and 17 others

Active not recruitingPhase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic AlterationsThis is a Phase III, randomized, open-label, multicenter, global study to compare the efficacy and safety of Datopotamab Deruxtecan (Dato-DXd) in combination with durvalumab and…NCT05687266·Phoenix, Arizona and 253 others

CompletedPatient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell CentersThis was a retrospective cohort study using secondary data from member sites of the National Alliance of Sickle Cell Centers (NASCC) with at least five patients who initiated…NCT05833022·Birmingham, Alabama and 10 others

TerminatedA Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid TumorsThis study is an open-label, multi-center, dose-escalation, dose-finding and expansion study in adult subjects with advanced solid tumors for whom no standard therapy is available.NCT03355066·Scottsdale, Arizona and 18 others

CompletedTack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee ArteriesThis is a prospective, multi-center, single-arm, non-blinded study designed to investigate the safety and efficacy of the Tack Endovascular System in the Mid/Distal Popliteal…NCT02942966·Yuma, Arizona and 48 others

CompletedSingle-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of PretomanidThis is a single-dose, open-label, randomized, four-period, four-treatment, crossover study in healthy adult subjects.NCT04309656·San Antonio, Texas

CompletedPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsThe purpose of this study is to determine the maximum dose of LDE225 and BKM120 that can be safely given together to patients and/or the dose that will be used in future studies.NCT01576666·Los Angeles, California and 22 others

CompletedA Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver ProblemsThis study is open to adults between 18 and 80 years of age. People with a body mass index (BMI) between 18 and 42 kg/m2 can take part.NCT06957756·Chandler, Arizona and 2 others

CompletedThe RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle CrampsThe purpose of the study is to learn about reducing the symptoms and severity of nighttime lower body muscle cramps in patients with and without cirrhosis.NCT05457322·Los Angeles, California and 5 others

CompletedRituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell LymphomaRATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritumomab tiuxetan can locate cancer cells and either kill them or deliver radioactive cancer-killing…NCT00058422·New York, New York and 1 other

PreviousPage 226 of 2103Next

Heart Diseasein Texas